Is CYT or JEPQ a better dividend investment in 2026?

CYT currently yields 66.23% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: CYT offers higher current income.

What is the dividend yield difference between CYT and JEPQ?

CYT has a forward dividend yield of 66.23% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 55.13 percentage points.

Home › Compare › CYT vs JEPQ

CYT vs JEPQ: Dividend Comparison 2026

CYT yields 66.23% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CYT wins by $835.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CYT

● Live price

66.23%

Share price

$3.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$880.0K

Annual income

$221,634.45

Full CYT calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — CYT vs JEPQ

📍 CYT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CYT	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CYT + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CYT pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYT

Annual income on $10K today (after 15% tax)

$5,629.14/yr

After 10yr DRIP, annual income (after tax)

$188,389.28/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, CYT beats the other by $186,559.58/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYT + JEPQ for your $10,000?

CYT: 50%JEPQ: 50%

100% JEPQ50/50100% CYT

Portfolio after 10yr

$462.4K

Annual income

$111,893.51/yr

Blended yield

24.20%

📊

Analyst Conviction Gap

Where Wall Street is split right now

CYT

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$2.00

-33.8% upside vs current

Range: $2.00 — $2.00

Altman Z

9.4

Piotroski

1/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYT buys

JEPQ buys

No recent congressional trades found for CYT or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCYTJEPQ

Forward yield	66.23% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$880.0K ✓	$44.8K
Annual income after 10y	$221,634.45 ✓	$2,152.59
Total dividends collected	$742.8K ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CYT vs JEPQ ($10,000, DRIP)

Year	CYT Portfolio	CYT Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$17,323	$6,622.52	$11,930	$1,110.39	+$5.4K → CYT
2	$29,256	$10,721.37	$14,133	$1,224.34	+$15.1K → CYT
3	$48,227	$16,923.00	$16,632	$1,340.46	+$31.6K → CYT
4	$77,675	$26,071.48	$19,454	$1,457.97	+$58.2K → CYT
5	$122,356	$39,243.54	$22,626	$1,576.08	+$99.7K → CYT
6	$188,694	$57,773.40	$26,175	$1,694.09	+$162.5K → CYT
7	$285,170	$83,268.01	$30,133	$1,811.32	+$255.0K → CYT
8	$422,742	$117,609.16	$34,531	$1,927.17	+$388.2K → CYT
9	$615,273	$162,940.02	$39,403	$2,041.08	+$575.9K → CYT
10	$879,977	$221,634.45	$44,787	$2,152.59	+$835.2K → CYT

CYT vs JEPQ: Complete Analysis 2026

CYT — Stock

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.

Full CYT Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this CYT vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYT vs SCHD CYT vs JEPI CYT vs O CYT vs KO CYT vs MAIN CYT vs XYLD CYT vs QYLD CYT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.